Cancer Immunology, Immunotherapy Issues Research Articles in March 2023 Edition
February 23, 2023
February 23, 2023
BASEL, Switzerland, Feb. 23 -- Cancer Immunology, Immunotherapy, a peer-reviewed journal that says it advances in the field of tumor immunology, published research articles on the following topics in its March 2023 edition:
Review Article:
* Intratumoral pro-oxidants promote cancer immunotherapy by recruiting and reprogramming neutrophils to eliminate tumors
Original Articles:
* Invariant NKT cells metabolically adapt to the acute myeloid leu . . .
Review Article:
* Intratumoral pro-oxidants promote cancer immunotherapy by recruiting and reprogramming neutrophils to eliminate tumors
Original Articles:
* Invariant NKT cells metabolically adapt to the acute myeloid leu . . .